Hydrogen gas activates coenzyme Q10 to restore exhausted CD8 T cells, especially PD-1Tim3terminal CD8 T cells, leading to better nivolumab outcomes in patients with lung cancer.
Akagi J, Baba H · Oncology letters · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

The publication “Hydrogen gas activates coenzyme Q10 to restore exhausted CD8 T cells, especially PD-1Tim3terminal CD8 T cells, leading to better nivolumab outcomes in patients with lung cancer.” is organized in H2HUBB under the research focus molecular hydrogen cancer supportive study 2020 akagi. The publication is cited as Akagi J, Baba H, Oncology letters, 2020. This uncontrolled human study examined Hydrogen gas activates coenzyme Q10 to restore exhausted CD8 T cells, especially PD-1Tim3terminal CD8 T cells, leading to better nivolumab outcomes in patients with lung cancer. The abstract describes Human participants; sample size 14. The abstract reports: In multivariate analysis, PD-1Tim-3terminal CD8 T cells (PDT+) were an independent poor prognostic factor in OS, and CoQ10 showed a tendency to be associated…. This is an automated editorial draft based on the abstract and requires source review before publication.
Molecular hydrogen cancer supportive study 2020 akagi overview
As mitochondrial activators exhibit synergistic effects with nivolumab, the current study investigated whether hydrogen gas also affects the clinical outcomes of nivolumab. Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Uncontrolled human study. Evidence type: Human clinical evidence. Research model or population: Human participants. Sample size: 14. Blinding: Unknown. Control status: Unknown.
Delivery method: Other or not reported.
Reported findings and scientific interpretation
For this molecular hydrogen cancer supportive study 2020 akagi, the study record reports the following: The abstract reports: In multivariate analysis, PD-1Tim-3terminal CD8 T cells (PDT+) were an independent poor prognostic factor in OS, and CoQ10 showed a tendency to be associated…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The reported sample size was small.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.